Diagonal Bio Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Karin Wehlin
Chief executive officer
SEK 924.0k
Total compensation
| CEO salary percentage | 95.24% |
| CEO tenure | 1.8yrs |
| CEO ownership | n/a |
| Management average tenure | 1.8yrs |
| Board average tenure | 4.8yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2025 | n/a | n/a | -SEK 9m |
| Jun 30 2025 | n/a | n/a | -SEK 9m |
| Mar 31 2025 | n/a | n/a | -SEK 9m |
| Dec 31 2024 | SEK 924k | SEK 880k | -SEK 10m |
| Sep 30 2024 | n/a | n/a | -SEK 10m |
| Jun 30 2024 | n/a | n/a | -SEK 12m |
| Mar 31 2024 | n/a | n/a | -SEK 11m |
| Dec 31 2023 | SEK 64k | n/a | -SEK 12m |
Compensation vs Market: Karin's total compensation ($USD97.72K) is below average for companies of similar size in the Swedish market ($USD292.62K).
Compensation vs Earnings: Karin's compensation has increased whilst the company is unprofitable.
CEO
Karin Wehlin (62 yo)
Ms. Karin Wehlin, MBA is Chief Executive Officer of Diagonal Bio AB (publ) since February 28, 2024 and was its Director since 2023 until June 12, 2024 and served as its Interim CEO from November 23, 2023 t...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | 1.8yrs | SEK 924.00k | no data | |
| Tech Advisor | no data | SEK 98.00k | no data | |
| Founder & Chief Scientific Officer | 5.8yrs | no data | no data | |
| Founding Partner | no data | no data | no data | |
| Chief Financial Officer | 1.4yrs | no data | no data |
Experienced Management: DIABIO's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Tech Advisor | 5.8yrs | SEK 98.00k | no data | |
| Independent Chair of the Board | 4.8yrs | SEK 257.00k | no data | |
| Member of Advisory Board | no data | no data | no data | |
| Independent Director | 4.8yrs | SEK 98.00k | no data | |
| Member of Advisory Board | no data | no data | no data |
Experienced Board: DIABIO's board of directors are considered experienced (4.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/17 00:05 |
| End of Day Share Price | 2025/11/17 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Diagonal Bio AB (publ) is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.